CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder

by Chihiro Namatame, Tatsuro Misu, Yoshiki Takai, Shuhei Nishiyama, Ichiro Nakashima, Kazuo Fujihara, Masashi Aoki
Published 2021-01-01